Special Reports
NSCLC (Issue 11)
Volume: 4
Issue: 2
Gastrointestinal Cancers: mCRC (Issue 9)
Volume: 1
Issue: 9
Hematologic Malignancies: Polycythemia Vera
Volume: 3
Issue: 3
Gastrointestinal Cancers: mCRC (Issue 8)
Gastrointestinal Cancers: mCRC (Issue 7)
Volume: 1
Issue: 7
Gastrointestinal Cancers: mCRC (Issue 6)
Volume: 1
Issue: 6
Genitourinary (Issue 3)
Head and Neck Cancers (Issue 4)
Volume: 3
Issue: 4
NSCLC (Issue 10)
Volume: 10
Issue: 10
Hematologic Malignancies: Multiple Myeloma
Volume: 2
Issue: 2
Breast Cancer (Issue 2)
Volume: 1
Issue: 2
NSCLC (Issue 9)
Volume: 9
Issue: 4
Melanoma (Issue 5)
Volume: 5
Issue: 2
Prostate Cancer (Issue 1)
Volume: 1
Issue: 1
NSCLC (Issue 8)
Volume: 8
Issue: 3
Precision Medicine
Volume: 2
Issue: 1
NSCLC (Issue 7)
Volume: 7
Issue: 2
Genitourinary (Issue 2)
Issue: 2
Gastrointestinal Cancers (Issue 5)
Volume: 4
Issue: 2
Melanoma (Issue 4)
Volume: 4
Issue: 1
Immunotherapy (Issue 5)
Volume: 5
Issue: 1
Gastrointestinal Cancers (Issue 4)
Volume: 4
Issue: 1
NSCLC (Issue 6)
Volume: 6
Issue: 1
Head and Neck Cancers (Issue 3)
Volume: 3
Issue: 1
Bone Health (Issue 1)
Volume: 1
Issue: 1
Breast Cancer (Issue 1)
Volume: 1
Issue: 1
NSCLC (Issue 5)
Volume: 5
Issue: 1
Immunotherapy (Issue 4)
Volume: 4
Issue: 1
Gastrointestinal Cancers (Issue 3)
Volume: 3
Issue: 1
Melanoma (Issue 3)
Volume: 3
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
